Counseling + Questionnaire Administration + Psilocybin for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 May 2023: Trial registered, NCT05847686
  2. 27 Jun 2023: Trial started, NCT05847686

The trials

NCT05847686: Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

State
Completed
Phase
Phase 1 and Phase 2
People
55 taking part
Started
27 Jun 2023
Primary completion
8 Apr 2024
Arms
Treatment (psilocybin, therapy)
Results
Posted on the registry
  1. 8 May 2023: Trial registered
  2. 27 Jun 2023: Trial started
  3. 17 Oct 2024: Trial completed
  4. 30 Apr 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.